OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial
Rahul Aggarwal, Deepak L. Bhatt, Michael Szarek, et al.
The Lancet Diabetes & Endocrinology (2025)
Closed Access | Times Cited: 3
Rahul Aggarwal, Deepak L. Bhatt, Michael Szarek, et al.
The Lancet Diabetes & Endocrinology (2025)
Closed Access | Times Cited: 3
Showing 3 citing articles:
Sodium–glucose co-transporter inhibitors—who would have guessed?
Anna Norhammar, Viveca Ritsinger
The Lancet Diabetes & Endocrinology (2025)
Closed Access
Anna Norhammar, Viveca Ritsinger
The Lancet Diabetes & Endocrinology (2025)
Closed Access
Incremental benefits of combined inhibition of SGLT1 and SGLT2 with sotagliflozin
Ram D. Bhatt, Bertram Pitt, Philippe Gabríel Steg, et al.
Progress in Cardiovascular Diseases (2025)
Closed Access
Ram D. Bhatt, Bertram Pitt, Philippe Gabríel Steg, et al.
Progress in Cardiovascular Diseases (2025)
Closed Access
Sotagliflozin provides additional benefits for high-fat diet-induced cardiac inflammatory injury by extra inhibiting P38MAPK and JNK
Jian-Chao Luo, Le-hao Jin, Yun-shan Zhong, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114631-114631
Closed Access
Jian-Chao Luo, Le-hao Jin, Yun-shan Zhong, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114631-114631
Closed Access
